MB 1
BULLETS
Free CME
Join now
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 212376

HIV Treatment Medical QID: 212376 (M1.OMB.18.1)
In scope icon M 3 B
QID 212376 (Type "212376" in App Search)
A 27-year-old man presents for followup 3 months after starting an antiretroviral regimen consisting of efavirenz, tenofovir, and emtricitabine. Labs drawn just prior to presentation reveal an undetectable viral load and a T-lymphocyte count of 317/mm^3. By comparison, his viral load was 6100/mL and his T-lymphocyte count was 146/mm^3 at the time of treatment initiation. He reports that he is tolerating the medications well and is not experiencing any major side effects. Which of the following treatment regimens should be recommended for this patient given the fully suppressed viral load?
Type in at least one full word to see suggestions list
Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options